Article
Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases.
Surgery today - 1 Oct 2026
Kanemitsu Kosuke, Hayashi Hiromitsu, Tagayasu Yoshiyuki, Tanizaki Takumi, Adachi Yuki, Ofuchi Takashi, Tajiri Takuya, Kitano Yuki, Okabe Hirohisa, Iwatsuki Masaaki
Abstract excerpt
PURPOSES: The Kirsten rat sarcoma viral oncogene homolog (KRAS) is defined as frequently mutated oncogenes in colorectal cancer. We aimed to clarify the clinical impact of KRAS mutation status on recurrence patterns, the surgical management of recurrent lesions, and prognostic outcomes after curative hepatectomy for colorectal liver metastases (CRLM). METHODS: The subjects of this retrospective study were 190...
Read the complete abstract on PubMedTopics
- Humans
- Liver Neoplasms
- Colorectal Neoplasms
- Proto-Oncogene Proteins p21(ras)
- Hepatectomy
